FARALLON CAPITAL MANAGEMENT LLC
Q2 2020 13F-HR Holdings
Net value change ($000)
+757,713
(6.6%)
New positions
32
Sold out positions
16
Turnover %
35.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| TMUS | 360,112 | NEW |
| AON | 331,368 | NEW |
| 58.com Inc. | 267,824 | NEW |
| BMY | 213,150 | NEW |
| NYT | 173,901 | NEW |
| MTCH | 148,615 | 48.3% |
| BX | 138,497 | 754.5% |
| IQV | 135,217 | 33.5% |
| META | 127,074 | 70.1% |
| QGEN | 123,336 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Allergan plc | -1,647,030 | -100.0% |
| CI | -127,650 | -57.6% |
| Forty Seven, Inc. | -105,439 | -100.0% |
| GD | -103,592 | -37.6% |
| FIS | -80,724 | -14.4% |
| Ra Pharmaceuticals, Inc. | -69,134 | -100.0% |
| WAB | -55,284 | -18.2% |
| ZYMEWORKS INC | -42,234 | -68.0% |
| PROGENICS PHARMACEUTICALS INC | -31,350 | -100.0% |
| GOOGL | -30,752 | -9.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
44,979
(0.4% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|